Cat. No. | Product Name | Field of Application | Chemical Structure |
---|---|---|---|
DC20145 | PF-05231023 Featured |
PF-05231023, a long-acting fibroblast growth factor 21 (FGF21) analog, is a FGF21-receptor agonist, suitable for development as a potential treatment for T2DM.
More description
|
![]() |
DC9442 | PF-04457845 Featured |
PF-04457845 is a potent and exquisitely selective inhibitor of FAAH, with an IC50 of 7.2 nM, and both analgesic and antiinflammatory effects in animal studies comparable to naproxen.
More description
|
![]() |
DC8382 | PF-03084014 (Nirogacestat) Featured |
PF-03084014 (PF-3084014) is a selective gamma-secretase inhibitor with IC50 of 6.2 nM in a cell-free assay. Phase 2.
More description
|
![]() |
DC2086 | PF-670462 Featured |
PF 670462 is a selective casein kinase, CK1ε and CK1δ inhibitor which also shows potency against 42 other kinases.
More description
|
![]() |
DC12178 | Pemigatinib Featured |
Pemigatinib is a selective FGFR inhibitor in development for the treatment of patients with cholangiocarcinoma.
More description
|
![]() |
DC7550 | PBIT Featured |
PBIT is a potent, cell-permeable inhibitor of Jumonji histone demethylase (JHDM). Innhibits JARID1B (also known as KDM5B or PLU1) with an IC₅₀ of about 3 μm in vitro.
More description
|
![]() |
DC11445 | Parthenolide Featured |
Parthenolide is a sesquiterpene lactone from the plant feverfew (T. parthenium).
More description
|
![]() |
DC8459 | Palovarotene(R 667) Featured |
Palovarotene (R-667, RO-3300074) is a selective retinoic acid receptor gamma(RAR-γ) agonist for the treatment of emphysema.
More description
|
![]() |
DC7223 | Palomid 529 (P529) Featured |
Palomid 529 (P529) is a novel potent inhibitor of both the mTORC1 and mTORC2 complexes with a GI50 of <35 μM in the NCI-60 cell lines panel; reduces phosphorylation of pAktS473, pGSK3βS9, and pS6 but no effect observed on pMAPK or pAktT308.
More description
|
![]() |
DC8638 | Paclitaxel Featured |
Paclitaxel is a microtubule polymer stabilizer with IC50 of 0.1 pM in human endothelial cells.
More description
|
![]() |
DC7477 | pac-1 Featured |
PAC-1 is a potent procaspase-3 activator with EC50 of 0.22 μM and the first small molecule known to directly activate procaspase-3 to caspase-3.
More description
|
![]() |
DC10798 | p38-α MAPK-IN-1 Featured |
p38-α MAPK-IN-1 is an inhibitor of MAPK14 (p38-α), with IC50 of 2300 nM in EFC displacement assay, and 5500 nM in HTRF assay.
More description
|
![]() |
DC7221 | P22077 Featured |
P22077 is a potent inhibitor of ubiquitin-specific protease (USP) 7 (EC50=8.6 uM), P22077 also inhibits the closely related deubiquitinase (DUB) USP47.
More description
|
![]() |
DC5188 | Sarecycline(P005672 hydrochloride) Featured |
P005672 is a phase II drug for antibacterial/anti-inflammatory acne treatment.
More description
|
![]() |
DC7222 | P005091(P5091) Featured |
P005091(P5091) is a selective and potent inhibitor of ubiquitin-specific protease 7 (USP7) with EC50 of 4.2 μM.
More description
|
![]() |
DC12312 | OTX008 (Calixarene 0118; PTX008) Featured |
OTX008 is a selective inhibitor of galectin-1.
More description
|
![]() |
DC5195 | Omecamtiv mecarbil (CK-1827452) Featured |
Omecamtivmecarbil (CK-1827452) is a specific cardiac myosinactivator and a clinical drug for left ventricular systolic heart failure.
More description
|
![]() |
DC20558 | STOML3 inhibitor OB-1 Featured |
OB-1 is a small-molecule inhibitor of STOML3 oligomerization that reverses pathological mechanical hypersensitivity in vivo; effectively inhibits the self-association of stomatin, STOML1 and STOML2 at 2 uM, but not podocin; reversibly reduces the sensitiv
More description
|
![]() |
DC10473 | NVS-PAK1-1 Featured |
NVS-PAK1-1 potently inhibits autophosphorylation of PAK1 (S144) at 0.25 µM in the Su86.86 cell line and MEK S289 phosphorylation with an IC50 = 0.21 in Su86.86 cells in which PAK2 is downregulated.
More description
|
![]() |
DC9769 | NVP-CGM097 (CGM-097) Featured |
NVP-CGM097 (CGM-097) is a potent and selective MDM2 inhibitor.
More description
|
![]() |
DC26035 | NUC-7738 Featured |
NUC-7738 is a phosphoramidate transformation of cordycepin (3’-deoxyadenosine; 3’-dA), a derivative of adenosine that was first isolated from Cordyceps sinensis.
More description
|
![]() |
DC5047 | NU7026 Featured |
NU7026 is a potent DNA-PK inhibitor with IC50 of 0.23 μM, 60-fold selective for DNA-PK than PI3K and inactive against both ATM and ATR.
More description
|
![]() |
DC7165 | NSI-189 Featured |
NSI-189 is a nootropic and neurogenic research chemical derived from nicotinamide and pyrazine.
More description
|
![]() |
DC10484 | NSC781406 Featured |
NSC781406 is a highly potent PI3K and mTOR inhibitor with an IC50 of 2 nM for PI3Kα.
More description
|
![]() |
DC20228 | NSC617145(WRN inhibitor) Featured |
NSC617145 is a Werner syndrome helicase (WRN) helicase inhibitor (IC50 = 250 nM).
More description
|
![]() |
DC9641 | NSC348884 Featured |
NSC348884 is a nucleolar phosphoprotein that displays several biological activities in ribosome biogenesis, cell proliferation, cytoplasmic/nuclear shuttle transportation, nucleic acid binding, ribonucleic cleavage, and centrosome duplication.
More description
|
![]() |
DC8783 | NS 9283 Featured |
NS 9283 is a positive allosteric modulator of α4β2 receptor; increases the potency of Ach-evoked currents ~60 fold without effecting the maximum efficacy (HEK293-hα4β2 cells).
More description
|
![]() |
DC8398 | NPS-1034 Featured |
NPS-1034 is a dual Met/Axl inhibitor with IC50 of 48 nM and 10.3 nM, respectively.
More description
|
![]() |
DC4111 | Nolatrexed (AG-337) Featured |
Nolatrexed (AG-337), inhibits purified recombinant human thymidylate synthase (TS) with a Ki of 11 nM, and displays non-competitive inhibition kinetics. It was further shown to inhibit cell growth in a panel of cell lines of murine and human origin, displ
More description
|
![]() |
DC7212 | NMS-873 Featured |
NMS-873 is a potent, selective allosteric VCP/p97 inhibitor with IC50 value of 20 nM (Wild Type, 1 mM ATP).
More description
|
![]() |